1-5 of 5
Robert J. Mayer
Close
Sort by
Journal Articles

Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461

Clinical Trials & Observations
Sherif S. Farag, Kellie J. Archer, Krzysztof Mrózek, Amy S. Ruppert, Andrew J. Carroll, James W. Vardiman, Mark J. Pettenati, Maria R. Baer, Mazin B. Qumsiyeh, Prasad R. Koduru, Yi Ning, Robert J. Mayer, Richard M. Stone, Richard A. Larson, Clara D. Bloomfield
Journal: Blood
Blood (2006) 108 (1): 63–73.
https://doi.org/10.1182/blood-2005-11-4354
Published: 2006
Journal Articles

Pre-Treatment Cytogenetics Predict Complete Remission and Long-Term Outcome in Patients (Pts) ≥60 Years with Acute Myeloid Leukemia (AML): Results from Cancer and Leukemia Group B (CALGB) 8461.

Sherif S. Farag, Kellie J. Archer, Krzysztof Mrózek, James W. Vardiman, Andrew J. Carroll, Mark J. Pettenati, Bayard L. Powell, Joseph O. Moore, Jonathan E. Kolitz, Maria R. Baer, Sandra H. Bigner, Prasad R. Koduru, Judith Stamberg, Robert J. Mayer, Richard M. Stone, Charles A. Schiffer, Richard A. Larson, Clara D. Bloomfield
Journal: Blood
Blood (2004) 104 (11): 568.
https://doi.org/10.1182/blood.V104.11.568.568
Published: 2004
Journal Articles

Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia

Clinical Trials & Observations
Mikkael A. Sekeres, Bercedis Peterson, Richard K. Dodge, Robert J. Mayer, Joseph O. Moore, Edward J. Lee, Jonathan Kolitz, Maria R. Baer, Charles A. Schiffer, Andrew J. Carroll, James W. Vardiman, Frederick R. Davey, Clara D. Bloomfield, Richard A. Larson, Richard M. Stone, for the Cancer and Leukemia Group B (CALGB)
Journal: Blood
Blood (2004) 103 (11): 4036–4042.
https://doi.org/10.1182/blood-2003-09-3118
Published: 2004
Journal Articles

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461): Presented in part at the 43rd annual meeting of the American Society of Hematology, Orlando, FL, December 10, 2001, and published in abstract form. 59

Clinical Trials & Observations
John C. Byrd, Krzysztof Mrózek, Richard K. Dodge, Andrew J. Carroll, Colin G. Edwards, Diane C. Arthur, Mark J. Pettenati, Shivanand R. Patil, Kathleen W. Rao, Michael S. Watson, Prasad R. K. Koduru, Joseph O. Moore, Richard M. Stone, Robert J. Mayer, Eric J. Feldman, Frederick R. Davey, Charles A. Schiffer, Richard A. Larson, Clara D. Bloomfield
Journal: Blood
Blood (2002) 100 (13): 4325–4336.
https://doi.org/10.1182/blood-2002-03-0772
Published: 2002
Journal Articles

Adult Patients With De Novo Acute Myeloid Leukemia and t(9; 11)(p22; q23) Have a Superior Outcome to Patients With Other Translocations Involving Band 11q23: A Cancer and Leukemia Group B Study

Krzysztof Mrózek, Kristiina Heinonen, David Lawrence, Andrew J. Carroll, Prasad R.K. Koduru, Kathleen W. Rao, Matthew P. Strout, Robert E. Hutchison, Joseph O. Moore, Robert J. Mayer, Charles A. Schiffer, Clara D. Bloomfield
Journal: Blood
Blood (1997) 90 (11): 4532–4538.
https://doi.org/10.1182/blood.V90.11.4532
Published: 1997